HIV

Illustration of a woman with depression symptoms overlaid with microscopic view of aging monocytes in blood, linking to study on women with and without HIV.

Study links monocyte “biological aging” in blood to emotional depression symptoms in women with and without HIV

04 maggio 2026 Riportato dall'IA Immagine generata dall'IA Verificato

A study of 440 participants from the Women’s Interagency HIV Study found that accelerated epigenetic aging in monocytes—an immune cell type—tracked more closely with emotional and cognitive depression symptoms such as hopelessness and loss of pleasure than with physical symptoms like fatigue. The work, published in The Journals of Gerontology: Series A, adds evidence that cell-type-specific aging measures could contribute to future biological tools to complement symptom-based depression screening, though researchers say more validation is needed before clinical use.

UNAIDS welcomes South Africa’s Lenacapavir HIV prevention launch

UNAIDS has welcomed South Africa’s rollout of Lenacapavir as a landmark step in HIV prevention. The injectable is now available at 360 public health facilities across six provinces. The drug has also been added to the national essential medicines list.

New HIV pill simplifies treatment for complex cases

01 giugno 2026 Riportato dall'IA

A new combination pill containing bictegravir and lenacapavir shows promise for people with HIV who require complex regimens. The phase three ARTISTRY 1 study found it performed as well as existing multi-pill options. Experts note its impact in South Africa will likely remain limited.

Salute

Low doses of THC show benefits for HIV treatment in animals

America

Gilead e Fiocruz firmano accordo per produzione iniezione anti-HIV in Brasile

America

Anvisa approva iniezione semestrale per prevenire l'HIV

Madhya Pradesh suspends three officials in Satna hospital HIV case

Following a probe panel's preliminary findings, Madhya Pradesh has suspended the blood bank in-charge and two lab technicians at Satna's Sardar Vallabhbhai Patel Government Hospital, where six thalassemia children contracted HIV from infected blood transfusions. A show-cause notice was issued to the former civil surgeon.

Promettenti progressi medici per il 2026

17 dicembre 2025 Riportato dall'IA

Nature Medicine ha selezionato studi clinici promettenti per il 2026, enfatizzando vaccini a lunga durata e trattamenti innovativi. Le aree chiave includono tubercolosi, HIV, long Covid, cellule staminali e colesterolo. Questi sviluppi potrebbero trasformare la lotta contro le malattie globali.

US aid withdrawal impacts South Africa's HIV testing

The withdrawal of US aid since February 2025 has led to a significant drop in HIV viral load tests in South Africa, according to data from the National Health Laboratory Service. Public health experts warn this signals serious setbacks in the country's HIV management program. While viral rebound rates have decreased, the reasons remain unclear.

Global HIV Trends Show Continued Decline

13 settembre 2025 Riportato dall'IA Verificato

An NPR report on September 12, 2025, highlighted the ongoing retreat of HIV worldwide, with fewer deaths, decreasing infections, and increased access to life-saving medications. These positive trends have persisted for decades.

18 maggio 2026 04:27